Microbot Medical Inc (NASDAQ:MBOT) Short Interest Down 49.3% in June

Microbot Medical Inc (NASDAQ:MBOT) was the recipient of a significant decline in short interest during the month of June. As of June 15th, there was short interest totalling 27,100 shares, a decline of 49.3% from the May 15th total of 53,500 shares. Approximately 0.9% of the shares of the stock are sold short. Based on an average trading volume of 46,000 shares, the days-to-cover ratio is currently 0.6 days.

A hedge fund recently bought a new stake in Microbot Medical stock. Geode Capital Management LLC acquired a new stake in Microbot Medical Inc (NASDAQ:MBOT) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 22,151 shares of the biotechnology company’s stock, valued at approximately $38,000. Geode Capital Management LLC owned 0.51% of Microbot Medical at the end of the most recent quarter. Institutional investors own 14.00% of the company’s stock.

Shares of NASDAQ:MBOT traded down $0.10 during trading hours on Friday, reaching $5.03. The stock had a trading volume of 13,991 shares, compared to its average volume of 16,315. Microbot Medical has a 1 year low of $1.38 and a 1 year high of $19.40. The business’s 50 day moving average is $5.11. The company has a quick ratio of 2.96, a current ratio of 2.96 and a debt-to-equity ratio of 0.03. The stock has a market cap of $22.10 million, a PE ratio of -2.09 and a beta of 4.89.

Microbot Medical (NASDAQ:MBOT) last announced its quarterly earnings data on Wednesday, May 15th. The biotechnology company reported ($0.48) EPS for the quarter. Equities research analysts anticipate that Microbot Medical will post -1.11 earnings per share for the current fiscal year.

Microbot Medical Company Profile

Microbot Medical Inc, a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company, through its ViRob and TipCAT micro-robotic technologies, is developing two product candidates, including the Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; and a self-propelling, semi-disposable endoscope, which is used in colonoscopy procedures.

See Also: Dividend Achievers

Receive News & Ratings for Microbot Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical and related companies with MarketBeat.com's FREE daily email newsletter.